Ependymomas are usually infratentorial and intraventricular. They originate from the ependymal cell lining of the ventricles. Cortical extraventricular supratentorial ependymomas are rare and fewer than 15 cases are reported worldwide. In pediatric age group, seven cases are reported. We report a rare case of 4-year-old boy with right frontoparietal anaplastic ependymoma who underwent gross total excision of lesion.
Introduction
Ependymomas are tumors derived from ependymal cells lining the ventricles or from the central canal of the spinal cord. It represents 3 to 9% of all neuroepithelial neoplasms, 6 to 12% of all pediatric brain tumors, and almost one-third of all brain tumors in patients younger than 3 years. Approximately 40% of ependymomas are supratentorial, whereas 60% are infratentorial in location. Ependymomas may manifest at any age (documented age ranges from 1 month to 81 years) with no sex predilection. Posterior fossa ependymomas are common in children (mean age: 6 years) and supratentorial ependymoma generally manifests in an older age group (mean age: 18-24 years). Although the lesion arises from the ventricular system, it can grow beyond the ventricles, through the cerebral tissue, representing the extraventricular form. It can exist in extraventricular structures, without any connection to ventricular system, representing the rare group of ectopic ependymoma. In the literature not more than 30 cases have been reported, of which 15 were diagnosed purely cortical and only 7 cases were anaplastic (grade III) lesions ►Table 1. 1 We report a rare case of solitary cortical pediatric anaplastic ependymoma.
Illustrative Case
A 4-year-old boy presented with progressively increasing headache and vomiting of 1-month duration. On examination he was drowsy and had left hemiparesis. A contrastenhanced computed tomographic (CT) scan of the brain showed a right frontal superficially located mixed-density lesion with heterogeneous enhancement (►Fig. 1). Intraoperatively gross total excision of the tumor was done via Tumor was moderately vascular and suckable. Margins were well defined. The postoperative period was uneventful. He made a good recovery and there was no fresh neurologic deficit. Histopathology examination showed plump spindle-shaped ependymal cells. The cells showed a tendency to form rosettes. There were pseudorosettes around blood vessels. Frequent mitosis, foci of microvascular proliferation, and large confluent areas of necrosis were seen. There were foci of dystrophic calcification (►Fig. 3). Immunohistochemistry was positive for glial fibrillary acidic protein and epithelial membrane antigen. Ki67 proliferation index was greater than 15% suggestive of anaplastic cortical ependymoma grade III.
Discussion
Although approximately half of the supratentorial ependymomas arise from the wall of third or lateral ventricles and are purely intraventricular, few may extend through adjacent cerebral tissue, representing extraventricular forms of ependymoma. Only few cases occur in distant places of the ventricular system, representing rare cases of ectopic lesions. It is speculated that ectopic ependymomas may arise from embryonic rests of ependymal tissue trapped in the developing cerebral hemispheres. Supratentorial ependymoma grows into third or lateral ventricle; it is predominant involving the brain parenchyma at the diagnosis. Hamano et al reported that 83% of supratentorial ependymomas are in the cerebral parenchyma. Owing to its parenchymal location, the supratentorial ependymoma tends to be larger in size at the diagnosis. Roncaroli et al found that 94% of supratentorial tumors manifest with a size larger than 4 cm and often contain a cystic component. Despite their large size in the cerebral hemispheres, symptoms are relatively mild until a later stage of presentation. Symptoms of raised intracranial pressure such as headache and vomiting are common, whereas focal signs as limb weakness and seizures are less prevalent. The principal differential diagnosis of extraventricular supratentorial ependymoma must include astrocytoma (both low-grade and glioblastoma multiforme), supratentorial primitive neuroectodermal tumor (PNET), ganglioglioma, gangliocytoma, and oligodendroglioma. They have no typical imaging features or findings; hence every lesion, with extension to the ventricular system, should make us suspicious of this fact. They are iso-to hypodense attenuations to surrounding normal brain tissue at nonenhanced CT. They are iso-to hypointense attenuations relative to normal white matter on nonenhanced T1-weighted magnetic resonance (MR) images and hyperintense attenuations on T2-and proton-density-weighted MR images. Foci of signal heterogeneity within a solid neoplasm represent methemoglobin, hemosiderin, necrosis, or calcification, which is very common in this tumor (40-80% of cases). Ependymomas can display variable contrast enhancement behavior but generally enhance moderately intensely at both CT and magnetic resonance imaging (MRI), with central areas of necrosis. 1 Histologically, the tumor cells are characteristically organized in perivascular pseudorosettes and, less commonly, ependymal rosettes. Although ependymomas are moderately cellular tumors with rare mitotic figures (World Health Organization [WHO] grade II lesions), our patient had a more aggressive tumor, classified as WHO grade III. Fewer than five ectopic anaplastic ependymomas were reported previously.
The best treatment is radical resection, because it appears that tumor resectability is the most important factor associated with recurrence. Solitary cortical (ectopic) tumors are comparatively easier to approach than lesions with connection to ventricles, having better outcome. Postoperative radiotherapy should be administered in every case of partially resected ependymomas or anaplastic tumors. At present chemotherapy and prophylactic cranio-spinal irradiation are not indicated as adjuvant treatment.
Age at presentation is also a significant prognostic factor. Patients younger than 3 years have a significantly worse outcome than older children or adults. The last prognostic variable is the duration of symptoms before diagnosis. Patients with symptoms before diagnosis less than 1 month have a worse outcome than those with a more protracted course.
Prognostic factors of ependymomas that positively contribute to progression-free survival and longer survival are still elusive, even in histologic characteristics. The 5-year progression-free survival rate for children overall is approximately 50% and 10-year survival rates for adults are 57.1% and 45%, respectively. Only total tumor resection is considered as a reliable prognostic factor for predicting longer survival time. Of patients with no radiologic evidence of residual tumor, 75% ± 15% will remain tumor free after 5 years as opposed to the group of patients with residual disease in which progression cannot be stopped.
An increased risk of recurrence was reported with a high histologic grade, incomplete resection, and a Karnofsky performance status that is 80 or less. 7, 8 Our patient was treated with radical surgery and subjected to postoperative radiotherapy, due to anaplastic grade of tumor. There was no evidence of gross residual tumor at postoperative imaging. The patient had a good recovery of neurologic symptoms. His left hemiparesis improved. Now he is regularly being followed in our outpatient clinic.
Consent
Written informed consent was obtained from the patient for publication of this case report and accompanying images.
